SFSebastian P. Fernandez

Sebastian P. Fernandez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sebastian P. Fernandez has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Jacques Barik

    Université Côte d'Azur, Nice, France; Institut de Pharmacologie Moléculaire et Cellulaire, CNRS UMR7275, Valbonne, France; Inserm U1323, Valbonne, France

    7 shared publications
  • Thomas Contesse

    Université Côte d'Azur, Nice, France; Institut de Pharmacologie Moléculaire & Cellulaire, Centre National de la Recherche Scientifique UMR 7275, Valbonne, France; Institut National de la Santé et de la Recherche Médicale U1323, Bordeaux, France

    4 shared publications
  • Loïc Broussot

    Université Côte d’Azur, Nice, France

    3 shared publications
  • Christelle Glangetas

    Université de Bordeaux, Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénérative, UMR 5293, Bordeaux, France

    2 shared publications
  • Hugo Fofo

    Université Côte d'Azur, Nice, France; Institut de Pharmacologie Moléculaire & Cellulaire, Centre National de la Recherche Scientifique UMR 7275, Valbonne, France; Institut National de la Santé et de la Recherche Médicale U1323, Bordeaux, France

    2 shared publications
  • Joana Gomes-Ribeiro

    Université Côte d'Azur, Nice, France; Institut de Pharmacologie Moléculaire et Cellulaire, CNRS UMR7275, Valbonne, France; Inserm U1323, Valbonne, France

    2 shared publications

Latest Publications

  • Open Access

    Ventral tegmental area circuits in defensive states: Emerging mechanisms of fear and anxiety

    by Joana Gomes-Ribeiro, Jacques Barik, Sebastian P. Fernandez


  • Open Access

    Social Stress Increases Anxiety by GluA1-Dependent Synaptic Strengthening of Ventral Tegmental Area Inputs to the Basolateral Amygdala

    by Thomas Contesse, Joana Gomes-Ribeiro, Lea Royon, Hugo Fofo, Anaelle Braine, Christelle Glangetas, Shiliang Zhang, M. Flavia Barbano, Mariano Soiza-Reilly, François Georges, et al.


  • Open Access

    A non-canonical GABAergic pathway to the VTA promotes unconditioned freezing

    by Loïc Broussot, Thomas Contesse, Renan Costa-Campos, Christelle Glangetas, Léa Royon, Hugo Fofo, Thomas Lorivel, François Georges, Sebastian P. Fernandez, Jacques Barik

    Freezing is a conserved defensive behaviour that constitutes a major stress-coping mechanism. Decades of research have demonstrated a role of the amygdala, periaqueductal grey and hypothalamus as core actuators of the control of fear responses, including freezing. However, the role that other modulatory sites provide to this hardwired scaffold is not known. Here, we show that freezing elicited by exposure to electrical foot shocks activates laterodorsal tegmentum (LDTg) GABAergic neurons projecting to the VTA, without altering the excitability of cholinergic and glutamatergic LDTg neurons. Selective chemogenetic silencing of this inhibitory projection, but not other LDTg neuronal subtypes, dampens freezing responses but does not prevent the formation of conditioned fear memories. Conversely, optogenetic-activation of LDTg GABA terminals within the VTA drives freezing responses and elicits bradycardia, a common hallmark of freezing. Notably, this aversive information is subsequently conveyed from the VTA to the amygdala via a discrete GABAergic pathway. Hence, we unveiled a circuit mechanism linking LDTg-VTA-amygdala regions, which holds potential translational relevance for pathological freezing states such as post-traumatic stress disorders, panic attacks and social phobias.


  • Open Access

    Dopamine and glutamate receptors control social stress-induced striatal ERK1/2 activation

    by Thomas Contesse, Loïc Broussot, Hugo Fofo, Peter Vanhoutte, Sebastian P. Fernandez, Jacques Barik


  • Open Access

    The microbial metabolite p -Cresol induces autistic-like behaviors in mice by remodeling the gut microbiota

    by Patricia Bermudez-Martin, Jérôme Ja Becker, N. Caramello, Sebastian P. Fernandez, Renan Costa-Campos, J. Canaguier, Susana Barbosa, L. Martinez-Gili, Antonis Myridakis, M.-E. Dumas, et al.

    Background: Autism Spectrum Disorders (ASD) are associated with dysregulation of the microbiota-gut-brain axis resulting in changes in microbiota composition as well as fecal, serum and urine levels of microbial metabolites. Yet, a causal relationship between dysregulation of the microbiota-gut-brain axis and ASD remains to be demonstrated. Here, we hypothesized that the microbial metabolite p -Cresol, which is more abundant in ASD patients compared to neurotypical individuals, could induce ASD-like behavior in mice. Results: Mice exposed to p -Cresol for 4 weeks in drinking water presented social behavior deficits, stereotypies, and perseverative behaviors, but no changes in anxiety, locomotion, or cognition. Abnormal social behavior induced by p -Cresol was associated with decreased activity of central dopamine neurons involved in the social reward circuit. Further, p -Cresol induced changes in microbiota composition and social behavior deficits could be transferred from p -Cresol-treated mice to control mice by fecal microbiota transplantation (FMT). We also showed that mice transplanted with the microbiota of p -Cresol-treated mice exhibited increased fecal p- Cresol levels compared to mice transplanted with the microbiota of control mice and identified possible p -Cresol bacterial producers. Lastly, the microbiota of control mice rescued social interactions, dopamine neurons excitability and fecal p -Cresol levels when transplanted to p- Cresol-treated mice. Conclusions: The microbial metabolite p- Cresol induces ASD core behavioral symptoms in mice via a gut microbiota-dependent mechanism. Our study paves the way for therapeutic interventions targeting the microbiota to treat patients with ASD.


  • Open Access

    Mesopontine cholinergic inputs to midbrain dopamine neurons drive stress-induced depressive-like behaviors

    by Sebastian P. Fernandez, Loïc Broussot, Fabio Marti, Thomas Contesse, Xavier Mouska, Mariano Soiza-Reilly, Hélène Marie, Philippe Faure, Jacques Barik

    Stressful life events are primary environmental factors that markedly contribute to depression by triggering brain cellular maladaptations. Dysregulation of ventral tegmental area (VTA) dopamine neurons has been causally linked to the appearance of social withdrawal and anhedonia, two classical manifestations of depression. However, the relevant inputs that shape these dopamine signals remain largely unknown. We demonstrate that chronic social defeat (CSD) stress, a preclinical paradigm of depression, causes marked hyperactivity of laterodorsal tegmentum (LDTg) excitatory neurons that project to the VTA. Selective chemogenetic-mediated inhibition of cholinergic LDTg neurons prevent CSD-induced VTA DA neurons dysregulation and depressive-like behaviors. Pro-depressant outcomes are replicated by pairing activation of LDTg cholinergic terminals in the VTA with a moderate stress. Prevention of CSD outcomes are recapitulated by blocking corticotropin-releasing factor receptor 1 within the LDTg. These data uncover a neuro-circuitry of depressive-like disorders and demonstrate that stress, via a neuroendocrine signal, profoundly dysregulates the LDTg.


  • Constitutive and Acquired Serotonin Deficiency Alters Memory and Hippocampal Synaptic Plasticity

    by Sebastian P Fernandez, Aude Muzerelle, Sophie Scotto-Lomassese, Jacques Barik, Agnès Gruart, José M Delgado-García, Patricia Gaspar

    Serotonin (5-HT) deficiency occurs in a number of brain disorders that affect cognitive function. However, a direct causal relationship between 5-HT hypo-transmission and memory, and underlying mechanisms, has not been established. We used mice with a constitutive depletion of 5-HT brain levels, (Pet1KO mice) to analyze the contribution of 5-HT to different forms of learning and memory. Pet1KO mice exhibited a striking deficit in novel object recognition memory, a hippocampal-dependent task. No alterations were found in tasks for social recognition, procedural learning or fear memory. Viral delivery of Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) was used to selectively silence the activity of 5-HT neurons in the raphe. Inhibition of 5-HT neurons in the median raphe, but not the dorsal raphe, was sufficient to impair object recognition in adult mice. In vivo electrophysiology in behaving mice showed that long-term potentiation in the hippocampus of 5-HT deficient mice was altered, and administration of the 5-HT1A agonist 8-OHDPAT rescued the memory deficits. Our data suggest that hyposerotonergia selectively affects declarative hippocampal-dependent memory. Serotonergic projections from the median raphe are necessary to regulate object memory and hippocampal synaptic plasticity processes, through an inhibitory control mediated by 5-HT1A receptors.


  • The Flavonoid Glycosides, Myricitrin, Gossypin and Naringin Exert Anxiolytic Action in Mice

    by Sebastian P. Fernandez, Michael Nguyen, Tin Thing Yow, Cindy Chu, Graham A. R. Johnston, Jane R. Hanrahan, Mary Chebib

    The consumption of flavonoid-rich foods, in particular fruits and vegetables, has been epidemiologically associated with a reduced risk of heart disease, neurodegenerative disease, cancer and other chronic diseases. Flavonoid glycosides, the main class of flavonoids, have been shown to exert CNS-mediated activities, particularly as sedative-hypnotics, analgesics or both, nevertheless no studies have evaluated these agents in anxiety. This study assessed the potential anxiolytic effect of three flavonoid glycosides, myrcitrin, naringin and gossypin, in the elevated plus maze test (EPM). Myricitrin (1 mg/kg) was effective on the EPM showing a clear anxiolytic effect with no signs of sedation. However, higher doses showed possible sedative and myorelaxation effects. Gossypin and naringin both shared a similar profile, with low doses (1 mg/kg) inducing a robust anxiolytic effect which diminished with increasing doses of the flavonoids. Higher doses of these two flavonoids showed a dramatic increase in the open arm exploration accompanied by a decrease in locomotor activity. Hence, naringin (30 mg/kg) and gossypin (30 mg/kg) induce both anxiolytic and sedative effects. These results suggest that flavonoid glycosides have the potential to exert a range of CNS-mediated biological activities.